Related Experiment Video
Updated: Jun 3, 2026

13:01
Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
Published on: June 3, 2022
Network-based pipeline for analyzing MS data: an application toward liver cancer
Wilson Wen Bin Goh1, Yie Hou Lee, Ramdzan M Zubaidah
1Department of Computing, Imperial College London, South Kensington, London, United Kingdom.
Journal of Proteome Research
|March 18, 2011
Summary
This study introduces a bioinformatics pipeline to enhance proteome coverage in hepatocellular carcinoma (HCC) research. The improved analysis reveals new molecular changes and potential immune evasion mechanisms during HCC progression.
Area of Science:
- Proteomics
- Bioinformatics
- Cancer Research
Background:
- High-throughput mass spectrometry (MS) in proteome analysis often yields incomplete datasets.
- Hepatocellular carcinoma (HCC) progression involves complex molecular changes not fully captured by current MS techniques.
Purpose of the Study:
- To develop and apply a two-stage functional analysis pipeline to improve proteome coverage in HCC.
- To identify molecular alterations and biological pathways associated with HCC progression using enhanced proteomic data.
Main Methods:
- Utilized iTRAQ reference data for hepatocellular carcinoma (HCC).
- Implemented a two-stage bioinformatics pipeline involving network cleaning, functional cluster analysis, and pathway enrichment analysis.
- Integrated network cleaning, community finding, and network analysis for expanded proteome coverage.
Main Results:
- The bioinformatics pipeline increased proteome coverage by over 1000 proteins beyond the initial 500 detected by MS.
- Identified densely connected protein clusters (PCNA, XRCC5, XRCC6, PARP1, PRKDC, WRN) involved in HCC progression from moderate to poor stages.
- Pathway enrichment analysis indicated that the moderate HCC stage is enriched in immune response proteins, suggesting immuno-evasion in the poor stage.
Conclusions:
- The developed pipeline significantly enhances proteome coverage, overcoming limitations of current MS technology.
- Uncovered key molecular players and pathway differences between moderate and poor HCC stages, highlighting potential immune evasion mechanisms.
- Provides a strategy for comprehensive proteome characterization in cancer research.
